The Bulls confirmed Wednesday that Ball (knee) has started playing in full-contact five-on-five scrimmages and hasn't faced any setbacks, Joe Cowley of the Chicago Sun-Times reports.
This is a massive hurdle for Ball to clear. The 2017 No. 2 overall pick hasn't played in an NBA game since Jan. 14, 2022 and has undergone three surgeries on his left knee during that stretch, including an experimental cartilage transplant for a new meniscus. Cowley notes that no professional athlete has ever returned to high-level competition after having that surgery. Ball picked up his $21.4 million player option for 2024-25, so the Bulls would certainly be incentivized to play him if he's healthy. However, it's unclear how he'll fit into Chicago's plans after the team traded for Josh Giddey this offseason.
Ball (knee) has been cleared to do "pretty much everything on the floor" and is on track to participate in 5-on-5 drills in August, Julia Poe of the Chicago Tribune reports.
Vice president of basketball operations Arturas Karnisovas provided an update on Ball's status after the first round of the 2024 NBA Draft and was optimistic Ball could be ready in time for training camp. Ball hasn't played since January of 2022 due to left knee issues that have required three surgeries, but he's been taking part in basketball activities and could be healthy enough to play in the 2024-25 season. The 26-year-old picked up his $21.4 million player option for the upcoming season.
Ball (knee) has picked up the $21.4 million player option in his contract for the 2024-25 season, Adrian Wojnarowski of ESPN reports.
Ball continues to work toward a potential comeback before he hits the open market next summer, as he signed a four-year, $80 million free-agent deal in 2021, so it was a no-brainer for him to pick up this option. Ball hasn't logged minutes at the NBA level since Jan. 2022, but both the player and the organization are hopeful he'll be able to step on the hardwood at some point during the 2024-25 campaign.
There is optimism that Ball (knee) will be able to play next season, K.C. Johnson of NBC Sports Chicago reports.
Ball hasn't logged any NBA minutes since Jan. 2022 due to a string of knee injuries. While the 26-year-old guard has yet to play 5-on-5 or participate in any contract drills, there is still optimism that he will return to action in 2024-25. Ball has a $21.4 million player option for next season.
Bulls head coach Billy Donovan said Friday that Ball (knee) has begun cutting, sprinting and jumping in controlled, non-contact situations, K.C. Johnson of NBC Sports Chicago reports.
The Bulls have exercised extreme caution with Ball's prolonged recovery from his third knee procedure since January 2021. Though he is merely running in a controlled setting, the activity seems to be a big step for the point guard in his recovery process. While he still presumably has several more hurdles to clear, the UCLA product is hoping to return at some point during the 2024-25 campaign.
Bulls' Lonzo Ball: Making progress, still no sprinting
Rotowire
Ball (knee) isn't experiencing pain during his day-to-day activities, which include a lot of mobility work, but he hasn't resumed sprinting yet, Ryan Taylor of NBC Sports Chicago reports.
Ball was expected to return to running in January, but all parties involved continue to proceed with caution. "Definitely doing much better in rehab," Ball said. "It's been a long process, obviously, longer than I'd like it to be. It's definitely cut out in stages and I keep checking off the boxes I'm supposed to and getting better each week." Coach Billy Donovan had similar sentiments: "He's doing different things on the court. He hasn't done any sprinting yet. I think everybody medically is pleased with the way it's progressing. Some of these movements he's doing now caused him pain before and aren't causing him pain. I know there was talk in January of him sprinting. I don't want to sit here and say he's behind schedule. I don't think that's the case because it's going well." Ball hasn't played since Jan. 2021, but he's staying positive and eyeing a return in 2024-25.
